RAIA DROGASIL S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.6 BRL | -0.18% |
|
+7.60% | -6.12% |
| May. 08 | Transcript : Raia Drogasil S.A., Q1 2024 Earnings Call, May 08, 2024 | |
| May. 07 | Raia Drogasil S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ETFs positioned on Raia Drogasil S.A.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.01% | 17 M€ | -8.09% | - | |
| 1.35% | 12 M€ | +15.09% | - | |
| 1.21% | 14 M€ | -1.33% | ||
| 1.19% | 0 M€ | -6.18% | ||
| 0.28% | 11 M€ | +8.03% | ||
| 0.11% | 454 M€ | +9.62% | - | |
| 0.11% | 2,867 M€ | +11.35% | - | |
| 0.11% | 153 M€ | +8.61% | - | |
| 0.09% | 4 M€ | -4.41% | - | |
| 0.05% | 112 M€ | +5.41% | - | |
| 0.03% | 7 M€ | +6.58% | - | |
| 0.01% | 45 M€ | 0.00% | - | |
| 0.01% | 34 M€ | +3.87% | - | |
| 0.01% | 391 M€ | +9.28% | - | |
| 0.00% | 34 M€ | +9.38% | - | |
| 0.00% | 39 M€ | +6.61% | - | |
| 0.00% | 306 M€ | +6.40% | - | |
| 0.00% | 25 M€ | -2.62% | - | |
| 0.00% | 146 M€ | -2.01% | - | |
| 0.00% | 7 M€ | +0.11% | - | |
| 0.00% | 105 M€ | +4.03% | - | |
| 0.00% | 1 M€ | 0.00% | - | |
| 0.00% | 29 M€ | -1.43% | - | |
| 0.00% | 17 M€ | +3.53% | - | |
| 0.00% | 15 M€ | +18.83% | ||
| 0.00% | 54 M€ | +1.01% | - | |
| 0.00% | 8 M€ | +1.24% | - |
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
Sector
Drug Retailers
Calendar
2024-08-05
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
27.65
BRL
Average target price
30.71
BRL
Spread / Average Target
+11.08%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.12% | 9.25B | |
| +32.54% | 1.32B | |
| -7.72% | 361M | |
| +0.79% | 269M | |
| +12.22% | 231M | |
| -39.42% | 93.72M | |
| -9.17% | 86.88M | |
| +19.44% | 59.62M |
- Stock Market
- Equities
- RADL3 Stock
- Funds and ETFs Raia Drogasil S.A.
